# Xeris Biopharma Holdings, Inc.: filings

XERS · Nasdaq · CIK 1867096 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xers.md) · [Financials](/companies/xers/financials.md) · [Filings](/companies/xers/filings.md) · [Insiders](/companies/xers/insiders.md)

## Reports and events: 81 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 152, 8-K 56, 144 24, 3 18, 10-Q 15, S-8 7, UPLOAD 7, CORRESP 6, DEFA14A 6, 10-K 5, DEF 14A 5, SC 13G 5, ARS 4, EFFECT 4, SC 13G/A 4, S-3 3, SCHEDULE 13G/A 3, 424B3 2, 425 2, 4/A 2, 424B5 1, 8-K12B 1, S-4 1, S-4/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 07:08 ET | [8-K](/filings/0001867096-26-000091.md) | 8.01 Other events | 0001867096-26-000091 |
| 2026-09-09 | 08:33 ET | [8-K](/filings/0001867096-26-000077.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-26-000077 |
| 2026-08-06 | 16:07 ET | [10-Q](/filings/0001867096-26-000065.md) | Quarterly report, period 2026-06-30 | 0001867096-26-000065 |
| 2026-08-06 | 07:12 ET | [8-K](/filings/0001867096-26-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-26-000063 |
| 2026-07-17 | 16:20 ET | [8-K](/filings/0001867096-26-000055.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001867096-26-000055 |
| 2026-06-30 | 16:06 ET | [8-K](/filings/0001867096-26-000048.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-26-000048 |
| 2026-06-11 | 07:16 ET | [8-K](/filings/0001867096-26-000045.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001867096-26-000045 |
| 2026-06-05 | 16:14 ET | [8-K](/filings/0001867096-26-000034.md) | 5.07 Shareholder vote results | 0001867096-26-000034 |
| 2026-05-07 | 16:09 ET | [10-Q](/filings/0001867096-26-000030.md) | Quarterly report, period 2026-03-31 | 0001867096-26-000030 |
| 2026-05-07 | 07:15 ET | [8-K](/filings/0001867096-26-000027.md) | 2.02 Results of operations | 0001867096-26-000027 |
| 2026-04-23 | 17:08 ET | [DEF 14A](/filings/0001867096-26-000021.md) | Proxy statement, period 2025-12-31 | 0001867096-26-000021 |
| 2026-04-21 | 16:27 ET | [8-K](/filings/0001867096-26-000020.md) | 5.02 Departure or appointment of officers or directors | 0001867096-26-000020 |
| 2026-03-02 | 16:25 ET | [10-K](/filings/0001867096-26-000016.md) | Annual report, period 2025-12-31 | 0001867096-26-000016 |
| 2026-03-02 | 07:08 ET | [8-K](/filings/0001867096-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-26-000012 |
| 2026-02-27 | 18:13 ET | [8-K](/filings/0001867096-26-000010.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-26-000010 |
| 2026-01-08 | 07:18 ET | [8-K](/filings/0001867096-26-000004.md) | 2.02 Results of operations | 0001867096-26-000004 |
| 2025-12-01 | 07:00 ET | [8-K](/filings/0001867096-25-000161.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000161 |
| 2025-11-06 | 16:07 ET | [10-Q](/filings/0001867096-25-000159.md) | Quarterly report, period 2025-09-30 | 0001867096-25-000159 |
| 2025-11-06 | 07:43 ET | [8-K](/filings/0001867096-25-000156.md) | 2.02 Results of operations | 0001867096-25-000156 |
| 2025-08-07 | 16:45 ET | [10-Q](/filings/0001867096-25-000136.md) | Quarterly report, period 2025-06-30 | 0001867096-25-000136 |
| 2025-08-07 | 08:02 ET | [8-K](/filings/0001867096-25-000130.md) | 2.02 Results of operations | 0001867096-25-000130 |
| 2025-06-04 | 17:17 ET | [8-K](/filings/0001867096-25-000104.md) | 5.07 Shareholder vote results | 0001867096-25-000104 |
| 2025-06-03 | 08:04 ET | [8-K](/filings/0001867096-25-000100.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000100 |
| 2025-05-08 | 16:12 ET | [10-Q](/filings/0001867096-25-000089.md) | Quarterly report, period 2025-03-31 | 0001867096-25-000089 |
| 2025-05-08 | 07:22 ET | [8-K](/filings/0001867096-25-000085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-25-000085 |
| 2025-04-23 | 17:01 ET | [DEF 14A](/filings/0001867096-25-000068.md) | Proxy statement, period 2024-12-31 | 0001867096-25-000068 |
| 2025-03-28 | 16:05 ET | [8-K](/filings/0001867096-25-000054.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000054 |
| 2025-03-06 | 16:07 ET | [10-K](/filings/0001867096-25-000039.md) | Annual report, period 2024-12-31 | 0001867096-25-000039 |
| 2025-03-06 | 07:21 ET | [8-K](/filings/0001867096-25-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-25-000034 |
| 2025-02-24 | 08:09 ET | [8-K](/filings/0001867096-25-000031.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000031 |
| 2025-01-10 | 07:17 ET | [8-K](/filings/0001867096-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-25-000017 |
| 2024-11-08 | 16:02 ET | [10-Q](/filings/0001867096-24-000187.md) | Quarterly report, period 2024-09-30 | 0001867096-24-000187 |
| 2024-11-08 | 07:13 ET | [8-K](/filings/0001867096-24-000183.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000183 |
| 2024-08-08 | 16:12 ET | [10-Q](/filings/0001867096-24-000162.md) | Quarterly report, period 2024-06-30 | 0001867096-24-000162 |
| 2024-08-08 | 07:15 ET | [8-K](/filings/0001867096-24-000157.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000157 |
| 2024-08-02 | 16:14 ET | [8-K](/filings/0001867096-24-000137.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001867096-24-000137 |
| 2024-07-08 | 07:14 ET | [8-K](/filings/0001867096-24-000124.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001867096-24-000124 |
| 2024-06-05 | 16:15 ET | [8-K](/filings/0001867096-24-000102.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001867096-24-000102 |
| 2024-05-09 | 16:19 ET | [10-Q](/filings/0001867096-24-000065.md) | Quarterly report, period 2024-03-31 | 0001867096-24-000065 |
| 2024-05-09 | 07:14 ET | [8-K](/filings/0001867096-24-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000062 |
| 2024-04-23 | 16:24 ET | [DEF 14A](/filings/0001867096-24-000053.md) | Proxy statement, period 2024-06-05 | 0001867096-24-000053 |
| 2024-03-06 | 16:10 ET | [10-K](/filings/0001867096-24-000031.md) | Annual report, period 2023-12-31 | 0001867096-24-000031 |
| 2024-03-06 | 07:27 ET | [8-K](/filings/0001867096-24-000024.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 8.01 Other events | 0001867096-24-000024 |
| 2024-01-04 | 07:09 ET | [8-K](/filings/0001867096-24-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000003 |
| 2023-11-09 | 16:10 ET | [10-Q](/filings/0001867096-23-000139.md) | Quarterly report, period 2023-09-30 | 0001867096-23-000139 |
| 2023-11-09 | 07:20 ET | [8-K](/filings/0001867096-23-000136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-23-000136 |
| 2023-10-16 | 07:12 ET | [8-K](/filings/0001867096-23-000130.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-23-000130 |
| 2023-09-29 | 16:55 ET | [8-K](/filings/0001867096-23-000125.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001867096-23-000125 |
| 2023-09-27 | 08:11 ET | [8-K](/filings/0001867096-23-000121.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001867096-23-000121 |
| 2023-08-08 | 16:11 ET | [10-Q](/filings/0001867096-23-000114.md) | Quarterly report, period 2023-06-30 | 0001867096-23-000114 |

Page 1 of 2. [Older](/companies/xers/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:37 ET. No prices; not investment advice.